Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma
Status:
Not yet recruiting
Trial end date:
2028-08-31
Target enrollment:
Participant gender:
Summary
In their "Magrolimab" research project, the investigators want to find out whether the new
drug Magrolimab in combination with conventional chemotherapy is well tolerated and whether
survival or progression-free survival improves.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Collaborators:
Swiss National Science Foundation University of Bern